Researcher
Yanina Jansen
- Keywords:Medicine
- Disciplines:Other translational sciences not elsewhere classified, Other basic sciences not elsewhere classified, Human and medical genetics not elsewhere classified, Other clinical sciences not elsewhere classified
Affiliations
- Laboratory for Medical and Molecular Oncology (Research group)
Member
From22 Mar 2021 → 23 Jun 2021 - UZB Other (Department)
Member
From1 Feb 2021 → 31 Jan 2022 - Surgery (Department)
Member
From1 Aug 2017 → 31 Jan 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From6 Oct 2016 → 19 Sep 2021 - Faculty of Medicine and Pharmacy (Faculty)
Member
From16 Oct 2015 → 23 Jun 2021 - Clinical sciences (Department)
Member
From1 Jan 2014 → 31 Jul 2017 - Immunology and Microbiology (Department)
Member
From15 Nov 2013 → 31 Dec 2013 - Medical Oncology (Department)
Member
From1 Oct 2013 → 31 Jul 2017 - Faculty of Medicine and Pharmacy (Faculty)
Member
From12 Sep 2012 → 10 Sep 2015 - Surgery (Department)
Member
From1 Aug 2012 → 31 Jul 2013 - Faculty of Medicine and Pharmacy (Faculty)
Member
From1 Sep 2008 → 29 Jun 2012
Publications
1 - 10 of 27
- Differentiation between normal and metastatic lymph nodes in patients with skin melanoma: preliminary findings using a DIXON-based whole-body MRI approach(2024)
Authors: Carola Brussaard, L. Faggioni, Fernando Esteban Ramirez Barbosa, Michel Vervoort, Yanina Jansen, Bart Neyns, Johan De Mey, Inneke Willekens, D. Cioni, E. Neri
- Intestinal ischemia in COVID-19 patients : a case series(2023)
Authors: Tobias Kristiaan Van De Winkel, Ward Patrick M Janssens, Nouredin Messaoudi, Martijn Schoneveld, J Stijns, E Van Eetvelde, Yanina Jansen
Pages: 1-8 - Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial(2022)
Authors: Julia Katharina Schwarze, Soizic Garaud, Yanina Jansen, G Awada, Valerie Vandersleyen, Jens Tijtgat, Alexandre de Wind, Paulus Kristanto, Teofila Seremet, Karen Willard-Gallo, et al.
- SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study(2022)
Authors: M Duinslaeger, Yanina Jansen, Michaël Jean-Marie Ruyssers
Pages: 28-39 - The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition(2021)
Authors: Judith M Versluis, Anne M Hendriks, Alison M Weppler, Lauren J Brown, Karlijn de Joode, Karijn P M Suijkerbuijk, Lisa Zimmer, Ellen W Kapiteijn, Clara Allayous, Douglas B Johnson, et al.
Pages: 72-83 - Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study(2021)
Authors: J Stijns, Martijn Schoneveld, Daniel Jacobs-Tulleneers Thevissen, Yanina Jansen, E Van Eetvelde, Marian Vanhoeij, Rastislav Kunda, Ward Patrick M Janssens, Nouredin Messaoudi, Michaël Jean-Marie Ruyssers, et al.
Pages: 748-758 - Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse(2021)
Authors: Yanina Jansen, Inneke Willekens, Teofila Seremet, G Awada, Julia Katharina Schwarze, Johan De Mey, Carola Brussaard, Bart Neyns
Pages: 1-13 - A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab(2021)
Authors: G Awada, Yanina Jansen, Julia Katharina Schwarze, Jens Tijtgat, Lennert Hellinckx, Odrade Gondry, Sim Vermeulen, Sarah Warren, Kelly A Schats, Pieter-Jan van Dam, et al.
Pages: 1-18 - Optimizing immunotherapy in patients with advanced melanoma(2021)
Authors: Yanina Jansen, Bart Neyns
- A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases(2020)
Authors: Yanina Jansen, Vibeke Kruse, Jurgen Corthals, Kelly A Schats, Pieter-Jan van Dam, Teofila Seremet, Carlo Heirman, Lieve Brochez, Mark Kockx, Kris Thielemans, et al.
Pages: 2589-2598